Skip to content

Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas

Multiple Hemangiomas and Large Cutaneous Hemangiomas of Infancy: Incidence of Hepatic Hemangiomatosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00374335
Enrollment
261
Registered
2006-09-11
Start date
2006-09-30
Completion date
2009-12-31
Last updated
2011-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemangioma

Keywords

prospective cohort study

Brief summary

This study will attempt to determine how common liver hemangiomas are in children with infantile hemangiomas by comparing liver ultrasound results in patients with 1-4 cutaneous hemangiomas, 5 or more cutaneous hemangiomas, or at least 1 large hemangioma versus ultrasound results in children without hemangiomas. Other objectives of the study include identifying specific risk factors in patients who have liver hemangiomas and identifying risk factors in children with symptomatic liver hemangiomas.

Detailed description

Hemangioma of infancy is the most common tumor of childhood occurring in 4% to 10% of infants. While most hemangiomas are benign in behavior and involute spontaneously, some can cause significant morbidity due to their location and size. In addition, some hemangiomas may be associated with extracutaneous hemangiomas that result in significant morbidity. Certain high risk hemangiomas of infancy, specifically multiple cutaneous hemangiomas or a solitary large hemangioma, have been associated with hepatic hemangiomatosis; however, the exact number or size of the cutaneous lesions at which the risk increases and the protocol for evaluating these patients remain controversial. The true prevalence of hepatic hemangiomatosis is unknown since there have been no large scale prospective studies evaluating clinically asymptomatic patients with cutaneous hemangiomas for the presence of hepatic hemangiomatosis. One of the primary objectives of this study is to determine the incidence of hepatic hemangiomatosis in patients with hemangiomas of infancy by comparing hepatic ultrasound imaging results of patients with 1-4 cutaneous hemangiomas, 5 or more cutaneous hemangiomas, or at least 1 large hemangioma \>30 cm2 versus imaging results in patients without cutaneous hemangiomas. The study will also attempt to identify specific risk factors associated with the development of hepatic hemangiomatosis and to identify associated risk factors in patients with clinically symptomatic hepatic hemangiomatosis.

Interventions

PROCEDUREabdominal ultrasound

abdominal ultrasound to detect hepatic hemangiomas

OTHERDermatologic Examination

Complete dermatologic examination

Sponsors

Medical College of Wisconsin
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
Columbia University
CollaboratorOTHER
Baylor College of Medicine
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
St. Justine's Hospital
CollaboratorOTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
CollaboratorOTHER
Children's Mercy Hospital Kansas City
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Months
Healthy volunteers
No

Inclusion criteria

* Infants less than 6 months of age * clinical diagnosis of 1-4 cutaneous hemangiomas * clinical diagnosis of 5 or more cutaneous hemangiomas * clinical diagnosis of at least 1 large cutaneous hemangioma greater than 30 cm2

Exclusion criteria

* Infants greater than 6 months of age

Design outcomes

Primary

MeasureTime frameDescription
Frequency of Hepatic Hemangiomas Identified on Abdominal Ultrasound2 yearsThe number of participants with cutaneous infantile hemangiomas (1-4 cutaneous hemangiomas, greater than 5 cutaneous hemangiomas, or at least one large cutaneous hemangioma) who were found to have hepatic hemangiomas on abdominal ultrasound
Presence of Hepatic Hemangiomas on Abdominal Ultrasound2 yearsThe number of participants with cutaneous infantile hemangiomas (1-4 cutaneous hemangiomas, greater than 5 cutaneous hemangiomas, or at least one large cutaneous hemangioma) who were found to have hepatic hemangiomas on abdominal ultrasound

Secondary

MeasureTime frameDescription
Risk Factors Associated With the Development of Hepatic Hemangiomas2 yearsWhich participants with cutaneous infantile hemangiomas (1-4 cutaneous hemangiomas, greater than 5 cutaneous hemangiomas, or at least 1 large cutaneous hemangioma) were found to have hepatic hemangiomas on abdominal ultrasound

Countries

United States

Participant flow

Participants by arm

ArmCount
Group 1
Cutaneous Hemangiomas (multiple \> 5, 1-4, or at least 1 hemangioms \>30 cm2)
261
Total261

Baseline characteristics

CharacteristicGroup 1
Age, Categorical
<=18 years
261 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age Continuous0.3 years
STANDARD_DEVIATION 0.1
Region of Enrollment
Canada
16 participants
Region of Enrollment
Spain
13 participants
Region of Enrollment
United States
232 participants
Sex: Female, Male
Female
192 Participants
Sex: Female, Male
Male
69 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 261
serious
Total, serious adverse events
0 / 261

Outcome results

Primary

Frequency of Hepatic Hemangiomas Identified on Abdominal Ultrasound

The number of participants with cutaneous infantile hemangiomas (1-4 cutaneous hemangiomas, greater than 5 cutaneous hemangiomas, or at least one large cutaneous hemangioma) who were found to have hepatic hemangiomas on abdominal ultrasound

Time frame: 2 years

ArmMeasureValue (NUMBER)
Group 1Frequency of Hepatic Hemangiomas Identified on Abdominal Ultrasound24 participants
Primary

Presence of Hepatic Hemangiomas on Abdominal Ultrasound

The number of participants with cutaneous infantile hemangiomas (1-4 cutaneous hemangiomas, greater than 5 cutaneous hemangiomas, or at least one large cutaneous hemangioma) who were found to have hepatic hemangiomas on abdominal ultrasound

Time frame: 2 years

Secondary

Risk Factors Associated With the Development of Hepatic Hemangiomas

Which participants with cutaneous infantile hemangiomas (1-4 cutaneous hemangiomas, greater than 5 cutaneous hemangiomas, or at least 1 large cutaneous hemangioma) were found to have hepatic hemangiomas on abdominal ultrasound

Time frame: 2 years

ArmMeasureValue (NUMBER)
Group 1Risk Factors Associated With the Development of Hepatic Hemangiomas24 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026